Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14029ExperimentalSmall molecule
Furafylline is a derivative of methylxanthine derivative. It was developed on the context of asthma as a long-acting alternative for theophylline.
- Mechanism
- Curator reviewed
Pharmacologically active on Cytochrome P450 1A2
- Formula / weight
- C18H16FN3 · 293.345 g/mol (avg)
Resolves to
Structure
InChIKey
HMZQULPVMKITSP-UHFFFAOYSA-NSMILESFC1=C(C=C(C=N1)C1CC2CCC1N2)C1=CC=C(C=C1)C#NTargets
What you can answer from here — as of October 12, 2026
Which drugs share a target with Furafylline, and which of those have an active Phase 3 trial?